Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Br J Radiol ; 81(966): 490-8, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18487389

ABSTRACT

The aim of this study was to evaluate the outcome and prognosticators for patients with resectable head and neck cancer (RHNC) undergoing definitive concurrent chemotherapy and radiotherapy (CCRT). In total, 110 RHNC patients receiving definitive CCRT to defer radical surgery were enrolled. Radiotherapy was given as either 2 Gy once daily with 70 Gy, or 1.2 Gy twice daily with 74.4 Gy. Chemotherapy involved the administration of 5-fluorouracil and cisplatin in two concomitant and two post-radiotherapy adjuvant cycles. 3 months after CCRT, MRI was performed to evaluate the response and determine further treatment plans. Survival outcome was calculated by the Kaplan-Meier method. Log-rank test and Cox regression analyses were used to estimate the significance of prognosticators. 4-year local-regional control, distant metastasis-free survival, disease-free survival and overall survival rates were 76.1%, 85.6%, 67.5% and 53.2%, respectively. Local recurrence (odds ratio = 4.09; p < 0.0001) and T3/T4 stage (odds ratio = 2.34; p = 0.01) were the independent factors associated with poor survival. T stage (odds ratio = 3.29; p = 0.03) and/or remission status on post-CCRT MRI (odds ratio = 7.22; p < 0.0001) were significantly associated with local control, distant metastasis-free survival and disease-free survival. 13 of 20 patients with imaging residuum had local recurrence, compared with 12 of 89 with complete remission (4-year local control rate of 27% vs 86%; p < 0.0001). Post-CCRT MRI may thus be used to predict the chance of a successful non-surgical approach.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/radiotherapy , Magnetic Resonance Imaging/standards , Adult , Aged , Chemotherapy, Adjuvant/methods , Cisplatin/administration & dosage , Female , Fluorouracil/administration & dosage , Humans , Infusions, Intravenous , Male , Middle Aged , Neoplasm Metastasis , Neoplasm Recurrence, Local/diagnosis , Prognosis , Radiotherapy, Adjuvant/methods , Retrospective Studies
2.
Kidney Int ; 69(1): 123-8, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16374432

ABSTRACT

Cystinuria is a recessively inherited aminoaciduria that leads to recurrent urolithiasis. It is caused by the defective transport of cystine and dibasic amino acids in the proximal renal tubules and intestinal epithelium. Two genes responsible for this, SLC3A1 and SLC7A9, are known. Patients with two SLC3A1 mutations are classified as type A cystinuria, whereas patients with two SLC7A9 mutations are classified as type B cystinuria. Few clinical and molecular data have been reported for Asian cystinuria patients. In this study, we determined the molecular basis of cystinuria in eight unrelated Chinese subjects. Coding exons and flanking introns of the SLC3A1 and SLC7A9 genes were directly sequenced after amplification by polymerase chain reaction. Five different SLC3A1 mutations were found. Two missense mutations, D210G and S547L, were novel. The other three SLC3A1 mutations (IVS6+2T>C, R181Q and R365W) have been described previously. In addition, four novel SLC7A9 mutations, C137R, c.730delG, IVS10+2_3delTG and IVS12+3insT, together with two previously reported mutations (A70V and G195R) were found. All patients except one carried compound heterozygous mutations. IVS12+3insT was detected in patients from two families. This is the first molecular genetic study on Chinese cystinuria patients. Three patients with type A cystinuria, two with type B cystinuria, and three carriers of type B cystinuria were identified. Our results suggest that the molecular basis of cystinuria is heterogeneous in our local population.


Subject(s)
Amino Acid Transport Systems, Basic/genetics , Amino Acid Transport Systems, Neutral/genetics , Cystinuria/genetics , Mutation , Adult , Child, Preschool , Cystine/metabolism , Female , Humans , Infant , Infant, Newborn , Male
3.
Article in Ml | WPRIM (Western Pacific) | ID: wpr-629887

ABSTRACT

We report two patients, who have used Pneumostat to replace the conventional underwater seal drainage system for recurrent pneumothorax. Both patients had required repeated chest tube insertion for recurrent pneumothorax and needed a longer hospital stay. Both patients were able to be discharged with the Pneumostat device and were reviewed in outpatient clinic. Both patients had optimal clinical improvement and chest X-ray showed no residual pneumothorax.


Subject(s)
Ambulatory Care , Chest Tubes , Drainage/instrumentation , Pneumothorax/therapy
4.
Article in English | MEDLINE | ID: mdl-11138199

ABSTRACT

Kalikmanov [Phys. Rev. E 59, 4085 (1999)] proposed a perturbation theory method to calculate the dielectric constant of dipolar hard sphere fluids using an infinitely long cylindrical container to avoid the depolarization. We demonstrate that while the method is very helpful, his theory appears to be incomplete because of the incorrect calculation of the corresponding three-body integrals. It is shown that with the correct consideration of these terms the theory is consistent with the results of earlier work in low-density limit, and at high densities the method yields the equation of Tani et al. [Mol. Phys. 48, 863 (1983)] for the dipolar hard sphere fluid dielectric constant.

SELECTION OF CITATIONS
SEARCH DETAIL
...